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Background: A commercially available self-test for the detection of Borrelia burgdorferi sensu lato in ticks was
evaluated for its ability to predict erythema migrans formation.
Findings: The self-test was performed on 127 Ixodes ricinus from 122 humans that reported tick bites at enrolment
and occurrence of symptoms during follow-up. The self-test gave negative results on all the 122 individuals, 14 of
whom reported erythema migrans (EM) at follow-up of which 10 were confirmed by their GP. The estimated
sensitivity of the self-test for prediction of EM formation is 0% (95% CI: 0%-28%).
Conclusions: This self-test is not suitable for reducing the number needed to treat in a post-exposure prophylaxis
setting as it already missed all the obvious early Lyme borreliosis cases.
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Lyme borreliosis is an emerging tick-borne disease,
caused by spirochetes of the Borrelia burgdorferi sensu
lato species complex [1,2]. The most characteristic mani-
festation of early Lyme borreliosis is erythema migrans
(EM), an expanding skin rash occurring after several
days or weeks at the site of the tick bite [3]. Late and
more serious Lyme borreliosis can manifest itself as a
multi-system disease with several skin, neurological, car-
diac and musculoskeletal manifestations [4]. Antibiotic
treatment of EM commonly prevents the development
of late and more severe disease stages. However, esti-
mates indicate that around 25% of Lyme borreliosis pa-
tients do not detect or do not receive treatment for EM
[5,6]. Prevention of Lyme borreliosis is difficult as no
absolute control measures are available as yet [7,8].
Post-exposure prophylaxis after tick-attachment may be
an effective way to reduce morbidity of Lyme borreliosis.
In one randomized trial performed in the United States,
prophylaxis was shown to prevent early Lyme borreliosis
after a tick bite, with a number needed to treat (NNT)* Correspondence: Hein.Sprong@rivm.nl
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stated.of 51 [9]. The NNT can be reduced if the ability of a test
to predict the development of Lyme borreliosis is in-
creased. Such a test could be based on Borrelia-infection
and attachment time of the tick [10,11]. It requires a
high sensitivity to be able to treat all persons at risk for
Lyme borreliosis, and moderate specificity to be able to
reduce the NNT. A self-test for the detection of B. burg-
dorferi sensu lato in ticks, the Careplus Tick-Test (Tropi-
care, Almere, Netherlands), is commercially available in
Europe. This Careplus Tick-Test is based on the detection
of B. burgdorferi sensu lato antigens in tick lysates. We
evaluated the ability of this test to predict EM formation.
In an ongoing web-based national survey (www.
tekenradar.nl), which started in 2012, more than 3000 in-
dividuals have reported tick bites, sent in the tick that bit
them, and were asked to fill out online questionnaires,
one at enrolment and follow-up questionnaires after
three, six and nine months. EM formation was actively
self-reported on the website or in the periodic question-
naires. For the test evaluation, we selected 122 individ-
uals together with 127 Ixodes ricinus nymphs or adults,
as 5 individuals sent in two ticks. To be able to assess
the ability of the Careplus Tick-test to predict EM for-
mation, we selected ticks from 25 individuals who re-
ported EM, 45 individuals who did not report EM at
follow up, and 52 individuals with unknown outcome byLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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Table 1 Summary of epidemiological data from this study
Outcome Criteria Frequency Sensitivity Specificity
Self-reported EM ● Self-reporting of EM between 0 and 3 months after reporting a tick bite 25 n/a n/a
Self-reported ● Same as self-reported EM 14 0% (0–22) n/a
EM treated with antibiotics ● No other tick bites reported besides those due to the tested ticks
● Self-reporting of GP prescribed antibiotic treatment for EM
GP-confirmed EM ● Same criteria as self-reported EM, treated with antibiotics 10 0% (0–28) n/a
● Written GP-confirmation of the self-reported EM diagnosis
No EM ● No reporting of EM between t = 0 and t = 3 months after a tick bite 45 n/a 100% (92–100)
Unknown ● Lost to follow-up after a tick bite 52 n/a n/a
Ticks from 122 individuals tested negative with the the Careplus Tick-test. The 25 self-reported EM cases were critically evaluated: Only those with confirmation by
their GP, were used to calculate the sensitivity of the self-test. Out of 14 self-reported EM cases treated with antibiotics, we received ten written informed consents
allowing us to contact the GP for confirmation of the EM diagnosis. These ten EM cases were subsequently confirmed by their GPs.
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sample from all reported tick bites as, we selected a
relatively large number of ticks from individuals with re-
ported EM. In order to consider only ticks that caused
EM, we have further restricted the EM cases by requir-
ing that: 1) no other tick bites were reported besides
those due to the tested ticks, and 2) participants who re-
ported that EM was treated with antibiotics for at least
one week upon GP prescription. This left us with 14
strong EM cases. From 10 of these 14 cases, we received
written informed consent to confirm the EM diagnosis
through their GP; all these 10 EM diagnoses were con-
firmed by the GP (Table 1). This left us with 14 EM
cases on which to base our analysis, of which 10 were
also confirmed by their GP. The incubation time of
these EM cases ranged from 7 to 44 days. We consi-
dered the outcomes of the other 11 EM cases as
uncertain.
The Careplus Tick-test was performed on all 127 ticks
of the 122 individuals according to the manufacturer’s
protocol except for a minor modification: the wooden
stick was replaced by a plastic pestle in order to improve
the homogenization of the tick. For the five individuals
with two ticks, three times the two ticks were tested
with one test, and twice the two ticks were tested separ-
ately. The self-test yielded negative results, regardless
of whether the ticks were obtained from persons without
EM-formation (n = 45), with EM-formation (n = 14),
with uncertain EM-formation (n = 11) and with un-
known outcome (n = 52). The Careplus Tick-test became
positive when about 5.105 spirochetes of a B. burgdorferi
senso stricto culture (B31-strain) were applied on the
membrane. Remnants of the tick lysates from the 14
persons with EM were subjected to DNA extraction and
a duplex QPCR to test whether B. burgdorferi sensu lato
was present [12]. Borrelia DNA was detected in samples
of 9 of the 14 self-reported EM-cases (64%) and 6 out of
10 (60%) of the GP-confirmed EM-cases, indicating the
presence of B. burgdorferi sensu lato spirochetes in theticks of at least 64% and 60% of these cases respectively:
The DNA detection was performed under suboptimal
conditions, as less than 5% of the tick lysate could be
used, whereas normally the whole tick lysate is used.
Using the same QPCR in other ticks enrolled through
the national web-based survey, 20% (444 out of 2213) of
the ticks from persons without EM-formation tested
positive.
All ticks from the 122 individuals in this study tested
negative in the Careplus Tick-test. Table 1 shows the
sensitivity and specificity for the prediction of EM
formation of the Careplus Tick-test. The sensitivity was
estimated to be 0% (95% CI: 0-22%) based upon the ticks
of 14 persons who had been bitten and self-reported
formation of EM and subsequent GP-prescribed anti-
biotic treatment [13]. If only the 10 GP-confirmed EMs
were included, the sensitivity was also estimated at 0%,
but with a higher 95% upper boundary (28%). The speci-
ficity was estimated to be 100% (95% CI: 92-100%),
based upon the 45 individuals without EM. This self-test
is not suitable for reducing the NNT in post-exposure
prophylaxis as it missed all the obvious early Lyme
borreliosis cases.
Competing interests
No conflict of interests to declare.
Authors’ contributions
HS, WP, CW and AV designed the study. MH, WP, AV, CW collected ticks,
epidemiological data and provided to participants. MH, CW and JC
performed the statistical and epidemiological analysis. AdL, MF set up and
performed laboratory tests, and interpreted these results. HS, CW and WP
interpreted the data. HS wrote the manuscript and all contributed to the
final version. All authors read and approved the final version of the
manuscript.
Author details
1Centre for Infectious Disease Control Netherlands, National Institute for
Public Health and Environment, Antonie van Leeuwenhoeklaan 9 P.O. Box 1
3720 BA, Bilthoven, The Netherlands. 2Environmental Systems Analysis Group,
Wageningen University, Wageningen, The Netherlands.
Received: 9 September 2013 Accepted: 30 November 2013
Published: 4 December 2013
Sprong et al. Parasites & Vectors 2013, 6:338 Page 3 of 3
http://www.parasitesandvectors.com/content/6/1/338References
1. Sprong H, Hofhuis A, Gassner F, Takken W, Jacobs F, van Vliet AJ, et al:
Circumstantial evidence for an increase in the total number and activity
of Borrelia-infected Ixodes ricinus in the Netherlands. Parasites Vectors
2012, 5:294. Epub 2012/12/19.
2. Medlock JM, Hansford KM, Bormane A, Derdakova M, Estrada-Pena A, George
JC, et al: Driving forces for changes in geographical distribution of Ixodes
ricinus ticks in Europe. Parasites Vectors 2013, 6:1. Epub 2013/01/04.
3. Tijsse-Klasen E, Pandak N, Hengeveld P, Takumi K, Koopmans MP, Sprong H:
Ability to cause erythema migrans differs between Borrelia burgdorferi
sensu lato isolates. Parasites Vectors 2013, 6:23. Epub 2013/01/24.
4. Stanek G, Wormser GP, Gray J, Strle F: Lyme borreliosis. Lancet 2012,
379(9814):461–73. Epub 2011/09/10.
5. Krupka M, Zachova K, Weigl E, Raska M: Prevention of lyme disease:
promising research or sisyphean task? Arch Immunol Ther Exp (Warsz)
2011, 59(4):261–75. Epub 2011/06/03.
6. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, et al:
An epidemiologic study of Lyme disease in southern Sweden. N Engl J
Med 1995, 333(20):1319–27. Epub 1995/11/16.
7. Wressnigg N, Pollabauer EM, Aichinger G, Portsmouth D, Low-Baselli A,
Fritsch S, et al: Safety and immunogenicity of a novel multivalent OspA
vaccine against Lyme borreliosis in healthy adults: a double-blind, rando-
mised, dose-escalation phase 1/2 trial. Lancet Infect Dis 2013, 8:680–689.
8. Braks M, van der Giessen J, Kretzschmar M, van Pelt W, Scholte EJ, Reusken
C, et al: Towards an integrated approach in surveillance of vector-borne
diseases in Europe. Parasites Vectors 2011, 4:192. Epub 2011/10/05.
9. Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, et al:
Prophylaxis with single-dose doxycycline for the prevention of Lyme
disease after an Ixodes scapularis tick bite. N Engl J Med 2001,
345(2):79–84. Epub 2001/07/14.
10. Hofhuis A, Herremans T, Notermans DW, Sprong H, Fonville M, van der
Giessen JW, et al: A prospective study among patients presenting at the
general practitioner with a tick bite or erythema migrans in The
Netherlands. PloS One 2013, 8(5):e64361. Epub 2013/05/23.
11. Tijsse-Klasen E, Jacobs JJ, Swart A, Fonville M, Reimerink JH, Brandenburg
AH, et al: Small risk of developing symptomatic tick-borne diseases
following a tick bite in The Netherlands. Parasites Vectors 2011, 4:17.
Epub 2011/02/12.
12. Heylen D, Tijsse E, Fonville M, Matthysen E, Sprong H: Transmission
dynamics of Borrelia burgdorferi s.l. in a bird tick community.
Environ Microbiol 2013, 15(2):663–73.
13. Zhou XH, Li CM, Yang Z: Improving interval estimation of binomial
proportions. Philos Transact A Math Phys Eng Sci 2008, 366(1874):2405–18.
Epub 2008/04/15.
doi:10.1186/1756-3305-6-338
Cite this article as: Sprong et al.: Sensitivity of a point of care tick-test
for the development of Lyme borreliosis. Parasites & Vectors 2013 6:338.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
